Literature DB >> 26106909

Microarray Determination of the Expression of Drug Transporters in Humans and Animal Species Used for the Investigation of Nasal Absorption.

Manar Al-Ghabeish1, Todd Scheetz2, Mahfoud Assem1, Maureen D Donovan1.   

Abstract

Mice and rats are commonly used to investigate in vivo nasal drug absorption, yet their small nasal cavities limit their use for in vitro investigations. Bovine tissue explants have been used to investigate drug transport through the nasal respiratory and olfactory mucosae, yet limited information is available regarding the similarities and differences among these animal models compared to humans. The aim of this study was to compare the presence of a number of important drug transporters in the nasal mucosa of these species. DNA microarray results for nasal samples from humans, rats, and mice were obtained from GenBank, while DNA microarray and RT-PCR were performed on bovine nasal explants. The drug transporters of interest include multidrug resistance, cation, anion, peptide, and nucleoside transporters. Each of the species (mouse, rat, cattle, and human) shows similar patterns of expression for most of the important drug transporters. Several transporters were highly expressed in all the species, including MRP1, OCTN2, PEPT2, and y+LAT2. While some differences in transporter mRNA and protein expression were observed, the transporter expression patterns were quite similar among the species. The differences suggest that it is important to be aware of any specific differences in transporter expression for a given compound being investigated, yet the similarities support the continued use of these animal models during preclinical investigation of intranasally administered therapeutics.

Entities:  

Keywords:  RT-PCR; animal models; drug transporters; microarray; nasal mucosa

Mesh:

Substances:

Year:  2015        PMID: 26106909      PMCID: PMC4671632          DOI: 10.1021/acs.molpharmaceut.5b00103

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  36 in total

1.  Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells.

Authors:  Gunilla Englund; Fredrik Rorsman; Anders Rönnblom; Urban Karlbom; Lucia Lazorova; Johan Gråsjö; Andreas Kindmark; Per Artursson
Journal:  Eur J Pharm Sci       Date:  2006-05-02       Impact factor: 4.384

Review 2.  Intranasal delivery: physicochemical and therapeutic aspects.

Authors:  Henry R Costantino; Lisbeth Illum; Gordon Brandt; Paul H Johnson; Steven C Quay
Journal:  Int J Pharm       Date:  2007-03-25       Impact factor: 5.875

3.  Expression, localisation and functional implications of the transporter protein PEPT2 in the upper respiratory tract.

Authors:  David Quarcoo; Tanja C Fischer; Werner Heppt; Hans-Dieter Lauenstein; Carolin Pilzner; Tobias Welte; David A Groneberg
Journal:  Respiration       Date:  2008-12-02       Impact factor: 3.580

Review 4.  Recent patents review on intranasal administration for CNS drug delivery.

Authors:  Viral Jogani; Kaustubh Jinturkar; Tushar Vyas; Ambikanandan Misra
Journal:  Recent Pat Drug Deliv Formul       Date:  2008

Review 5.  Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2.

Authors:  Eva M del Amo; Arto Urtti; Marjo Yliperttula
Journal:  Eur J Pharm Sci       Date:  2008-07-05       Impact factor: 4.384

Review 6.  Intranasal drug delivery: how, why and what for?

Authors:  Anaísa Pires; Ana Fortuna; Gilberto Alves; Amílcar Falcão
Journal:  J Pharm Pharm Sci       Date:  2009       Impact factor: 2.327

7.  Role of organic cation transporters in dopamine uptake across olfactory and nasal respiratory tissues.

Authors:  Nagendra V Chemuturi; Maureen D Donovan
Journal:  Mol Pharm       Date:  2007-09-25       Impact factor: 4.939

8.  Expressions of the multidrug resistance-related proteins in the rat olfactory epithelium: a possible role in the phase III xenobiotic metabolizing function.

Authors:  Hideaki Kudo; Yoshiaki Doi; Sunao Fujimoto
Journal:  Neurosci Lett       Date:  2009-10-29       Impact factor: 3.046

9.  Comparative gene expression profiles of intestinal transporters in mice, rats and humans.

Authors:  Hye-Ryoung Kim; Sung-Won Park; Hee-Jung Cho; Kyung-Ae Chae; Ji-Min Sung; Jin-Suk Kim; Christopher P Landowski; Duxin Sun; A M Abd El-Aty; Gordon L Amidon; Ho-Chul Shin
Journal:  Pharmacol Res       Date:  2007-06-23       Impact factor: 7.658

10.  Adenosine deaminase 1 and concentrative nucleoside transporters 2 and 3 regulate adenosine on the apical surface of human airway epithelia: implications for inflammatory lung diseases.

Authors:  Andrew J Hirsh; Jaclyn R Stonebraker; Catja A van Heusden; Eduardo R Lazarowski; Richard C Boucher; Maryse Picher
Journal:  Biochemistry       Date:  2007-08-15       Impact factor: 3.162

View more
  3 in total

Review 1.  Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?

Authors:  Clément Mercier; Nathalie Perek; Xavier Delavenne
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

2.  Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects.

Authors:  Philip Krieter; C Nora Chiang; Shwe Gyaw; Phil Skolnick; Rebekah Snyder
Journal:  Drug Metab Dispos       Date:  2019-04-16       Impact factor: 3.922

3.  Demonstration of Nucleoside Transporter Activity in the Nose-to-Brain Distribution of [18F]Fluorothymidine Using PET Imaging.

Authors:  Laura L Boles Ponto; Jiangeng Huang; Susan A Walsh; Michael R Acevedo; Christine Mundt; John Sunderland; Maureen Donovan
Journal:  AAPS J       Date:  2017-12-07       Impact factor: 4.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.